VYCO News Alert Vycor Medical Inc. (VYCO) 1.5100 12/25/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Vycor Medical Inc. (VYCO) 1.5100 $VYCO

Vycor Announces Commercial Launch of NeuroEyeCoach(TM) Professional Physician Edition
ACCESSWIRE - Mon Nov 24, 7:00AM CST
BOCA RATON, FL / ACCESSWIRE / November 24, 2014 / Vycor Medical, Inc. ("Vycor" (OTCQB-VYCO), a provider of innovative and superior surgical and therapeutic solutions, announced that its wholly owned subsidiary NovaVision, Inc. had successfully completed the development of and was in the process of commercially launching its NeuroEyeCoach(TM) Professional Physician Edition. The launch of this Edition was the result of demand from physicians who wanted to be able to initiate patients on the NeuroEyeCoach(TM) program in their office or clinic and then have patients continue the program at home, supported by NovaVision staff, while being able to monitor the patient's progress through a dedicated portal access point.

Vycor Medical to Present at the LD Micro Conference on December 3
ACCESSWIRE - Tue Nov 18, 7:00AM CST
BOCA RATON, FL/ ACCESSWIRE / November 18, 2014 / Vycor Medical, Inc. ("Vycor" (OTCQB-VYCO), a provider of innovative and superior surgical and therapeutic solutions, is pleased to announce that Peter Zachariou, Chief Executive Officer and David Cantor, President, will present at the LD MICRO Conference at 9:30 a.m. (PT), Track 3, on Wednesday, December 3, 2014. The conference will be held December 2-4, 2014 at the Luxe Sunset Boulevard Hotel, 11461 Sunset Boulevard, Los Angeles, CA. The Company's group presentation will be available for the public to access at http://wsw.com/webcast/ldmicro7/vyco. This webcast will be archived for 90 days following the live presentation. Vycor Medical management will be available during the day on December 3 for one-on-one meetings. Please contact LD MICRO to schedule a meeting.

Vycor Medical Releases Financial Results for Third Quarter and First Nine Months of 2014
ACCESSWIRE - Wed Nov 12, 12:00PM CST
Vycor VBAS up 41% for first nine months over same period in 2013 Non-GAAP Net Operating Loss reduced by 12%

VYCOR: "On the Cusp of the Next Big Healthcare Trend"
ACCESSWIRE - Mon Nov 10, 8:23AM CST
Vycor: "On the Cusp of the Next Big Healthcare Trend"
MDVN: 99.23 (+1.23), ABMD: 38.46 (+0.13), JNJ: 104.59 (+0.31), AMGN: 160.67 (+3.15), EXAS: 27.60 (+0.39), ARAY: 7.54 (+0.19), HOLX: 26.89 (+0.10), PBYI: 189.96 (+0.12)

Leading Neurosurgeon to Present at Vycor's Booth at Congress of Neurological Surgeons in Boston
Marketwired - Thu Oct 16, 7:31AM CDT
Vycor Medical, Inc. ("Vycor" (OTCQB: VYCO), a provider of innovative and superior surgical and therapeutic solutions, is pleased to announce that Dr. Antonio Bernardo, from the Department of Neurological Surgery at Weill Cornell Medical College, will present and field questions on his recent work on minimally invasive neurosurgical approaches through Vycor Medical's ViewSite(TM) Brain Access System (VBAS) at the 2014 meeting of the Congress of Neurological Surgeons in Boston, Massachusetts. Dr. Bernardo will demonstrate the novel techniques developed in his laboratory that may mitigate the risk of postoperative seizures, aphasia, and venous complications through minimization of brain retraction in the middle fossa approach and other selected skull base procedures while improving cosmetic outcomes. Additionally, by limiting the range of instrument movement and protecting the surrounding tissues from instruments within the working channel, the tubular retractor may reduce inadvertent iatrogenic instrumental injury and thermal injury from the endoscope light or electrocautery.

Vycor Continues to Execute on Its Stated Strategic Goal of Expanding Internationally
Marketwired - Mon Oct 13, 7:01AM CDT
Vycor Medical, Inc. ("Vycor" (OTCQB: VYCO), a provider of innovative and superior surgical and therapeutic solutions, announced that it had made significant in-roads into a number of key international markets. Most recently it has entered into a distribution agreement with Eurotech, a leading Russian distributor of surgical devices, and secured its first order. In addition to Russia, Vycor has identified and started to work with neurosurgical distributors in the following markets: Brazil, France, South Africa, Sri Lanka and Taiwan. In each of these markets, Vycor has entered into either evaluation or distribution agreements and is now going through local regulatory approvals. Including these countries, Vycor now has international agreements in place for VBAS in Australia, Belgium, Brazil, Canada, China, France, Germany, Greece, Holland, Hong Kong, Italy, Japan, Korea, Russia, South Africa, Spain, Sri Lanka, Sweden, Taiwan and the UK.

Prominent Researchers to Present Minimally Invasive Surgeries Utilizing Vycor Medical's VBAS at Congress of Neurosurgery
Marketwired - Fri Oct 10, 7:30AM CDT
Vycor Medical, Inc. ("Vycor" (OTCQB: VYCO), a provider of innovative and superior surgical and therapeutic solutions, is pleased to announce that researchers from the Department of Neurological Surgery at Weill Cornell Medical College will present their recent work on minimally invasive neurosurgical approaches through Vycor Medical's ViewSite(TM) Brain Access System (VBAS) at the 15th European Congress of Neurosurgery in Prague. Prof. Antonio Bernardo, Director of the Surgical Innovations Lab for Skull Base and Microneurosurgery at Weill Cornell, will deliver a presentation on minimally invasive supraorbital and middle fossa approaches to intracranial targets on Tuesday, October 14th at 15:30 in Hall E.

Weill Cornell Neurosurgeons to Present Procedures Carried Out Using Vycor's VBAS at International Congress on Minimally Invasive Techniques in Neurosurgery
Marketwire - Thu Sep 04, 7:36AM CDT
Vycor Medical, Inc. ("Vycor" (OTCQB: VYCO), a provider of innovative and superior surgical and therapeutic solutions, announced that researchers from the Department of Neurological Surgery at Weill Cornell Medical College will present their recent work on minimally invasive neurosurgical approaches using Vycor Medical's ViewSite(TM) patented Brain Access System (VBAS) next week, from September 11 to 13, at the 2nd International Congress on Minimally Invasive Techniques in Neurosurgery in Xian, China. Members of the research team will meet with surgeons before the conference to demonstrate novel techniques that may help diminish the risk of retraction injury while surgically accessing the third ventricle and which may mitigate the risk of post-operative seizures, aphasia, and venous complications through minimization of brain retraction in the middle fossa approach while improving cosmetic outcomes. The team will also provide an in-depth technical demonstration of these techniques to local surgeons.

Vycor Reports 41% Year-to-Date Revenue Growth
Marketwire - Tue Aug 12, 7:31AM CDT
Vycor Medical, Inc. ("Vycor" (OTCQB: VYCO), today announced financial results for the second quarter and first six months of 2014.

New Image Guided VBAS Prototype Work Completed
Marketwire - Thu Aug 07, 7:00AM CDT
Vycor Medical, Inc. ("Vycor" (OTCQB: VYCO), a provider of innovative and superior surgical and therapeutic solutions, announced that it had successfully completed the development of new prototypes of its patented ViewSite(TM) Brain Access System ("VBAS" device that will be fully compatible with selected image-guided systems. The device has been specifically designed to house the pointer utilized in image-guided systems. The pointer will be firmly held in place in the introducer through a novel approach while the working channel will remain unchanged. The Company will now commence the testing of these devices. Initially the Company plans on manufacturing four new devices targeted at this market, this development being spurred by strong neurosurgeon demand. VBAS is currently approved in over 170 hospitals in the U.S. and more than 6,500 surgeries have been performed worldwide utilizing VBAS.

Vycor Medical Boosts Shareholder Equity by $2.4 million
Marketwire - Tue Aug 05, 7:31AM CDT
Vycor Medical, Inc. ("Vycor" or the "Company" (OTCQB: VYCO), today announces that its largest shareholder, Fountainhead Capital Management Limited ("Fountainhead" , along with certain other related and non-related parties (together, the "Fountainhead Parties" , has agreed to exchange all of its $2,355,587 of debt into an equivalent amount of preferred equity in the company.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Maryland Handgun Ban Suit Puts Ruger in Legal Crossfire

Updated Category News Views 96

A January Deadline With Real Commercial Teeth Maryland has turned a trigger-design dispute into a fresh legal and retail headache, and the clock is not polite about it. The National Shooting Sports Foundation filed suit against the state over S.B. 334, which is scheduled to take effect Jan. 1, 2027. The law bars sales of certain pistols with cruciform trigger bars,...

Continue Reading
Healthcare's Prevention Puzzle Needs Better Incentives

Updated Category News Views 113

When Savings Belong to the Next Plan A patient changing insurance plans can turn prevention into nobody’s asset. That is the uncomfortable little engine inside Russell Greenfield’s recent argument: an insurer may pay today for a program that helps prevent chronic illness, only to watch the eventual savings land with another plan after the member moves on. The person...

Continue Reading
Webster First Takes Aim at the Youth Money Literacy Gap

Updated Category News Views 86

Money mistakes get expensive long before anyone calls them mistakes. That is the uncomfortable point beneath Webster First Federal Credit Union CEO John Thomasian's November 20, 2026 discussion of financial literacy: plenty of young adults are entering the real financial world with a card, a loan offer, and a phone full of banking apps, but no sturdy framework for using...

Continue Reading
CVRx Lawsuit Puts Barostim Sales Claims Under Hard Scrutiny

Updated Category News Views 121

August 7 turned a compliance disclosure into a wrecking ball for CVRx shareholders. After the company revealed a Department of Justice civil investigative demand and cut its outlook, the stock dropped $3.55, or 60%, to close at $2.39. That is not a routine bad quarter getting punished. It is the market abruptly questioning whether the sales engine, the revenue it...

Continue Reading
Jalisco’s Culinary Push Puts Tourism Strategy in Focus

Updated Category News Views 50

A destination sells itself twice: first with a memorable meal, then with a reason to come back. Jalisco’s stated effort to connect the world’s cuisines through The 50 Best Gastronomic Experiences belongs in that second category. It is not merely restaurant chatter. It reads as part of a broader attempt to make the state’s tourism offering feel deeper, more varied...

Continue Reading
Nevada’s Space Academy Bid Has Assets, Not a Win Yet

Updated Category News Views 29

Desert acreage and a moon-landing backstory make for a handsome pitch, but Nevada is still standing at the starting line. The state has submitted its official response to NASA’s Request for Information for a proposed United States Space Academy, and the new promotional video is meant to show why the Silver State belongs in the conversation. Fair enough. There is real...

Continue Reading
Faex Health Adds Ebola and H. pylori AI Screening Tools

Updated Category News Views 82

A smartphone pointed at a toilet is an awkward place to hunt for medical progress, yet Faex Health is making a serious attempt to turn that daily evidence into an early-warning tool. The company has added investigational pre-screening capabilities for Ebola virus disease and Helicobacter pylori, or H. pylori, bringing its internally validated panel to 18 gastrointestinal...

Continue Reading
Rock Gate Buys Aviation Niche Player Blast Deflectors

Updated Category News Views 167

Jet exhaust is not glamorous, but somebody has to keep it from battering everything nearby. Rock Gate Partners’ acquisition of Blast Deflectors, Inc. puts money behind one of those stubbornly unsexy industrial niches where engineering credibility matters far more than a flashy sales pitch. The transaction closed October 16, 2026, and Northborne Partners announced...

Continue Reading
Saturn and Tileward Put GPU Memory Back to Work Now

Updated Category News Views 49

GPU memory is the tollbooth nobody notices until the whole AI highway backs up. Saturn Cloud’s new partnership with Tileward goes straight at that constraint: use compressed open-model weights, free memory on hardware already installed, and turn that reclaimed capacity into more tokens that an operator can actually sell. It is not glamorous. It may be one of the more...

Continue Reading
Greenberg Traurig Adds Privacy Muscle in Denver Office

Updated Category News Views 162

Privacy work used to be the legal department's back-room plumbing; now it can jam an entire product launch. That is why Greenberg Traurig's decision to bring Amber Mednick in as of counsel in Denver deserves more attention than the usual law-firm hiring blurb. This is not a splashy deal, and nobody should pretend one lateral hire rewrites the competitive map. Still, it is...

Continue Reading

Top 5 Most Recently Viewed Articles

Beta Glucan Market Set to Exceed USD 31 Billion by 2030

Updated Category News Views 56

Exploring the Growth of the Beta Glucan Market The beta glucan market is experiencing remarkable growth, largely driven by increasing awareness of its health benefits. More and more consumers are recognizing the importance of supporting their immune systems and managing cholesterol levels, which has led to a surge in demand across numerous sectors, including...

Continue Reading
AiPPT.com: Crafting the Next Era of AI-Driven Presentations

Updated Category News Views 177

Transforming Presentations with AiPPT.com In the evolving landscape of digital work, AiPPT.com stands out as a leading provider of AI-native tools that are reshaping the way presentations are crafted. As an advanced AI presentation maker, AiPPT.com is committed to enhancing user experiences by making the process of creating engaging and professional presentations much...

Continue Reading
Acme Mills Launches Natura: Revolutionizing Sustainable Fabrics

Updated Category News Views 244

Revolutionizing Textile Innovation with Natura Acme Mills Company, a recognized pioneer in textile manufacturing, has proudly unveiled its latest innovation, Natura. This new line of bio-based polylactic acid (PLA) fabrics aims to replace traditional petroleum-based materials such as PET, PP, and Nylon. With Natura, Acme Mills is not just promoting a product; it is...

Continue Reading
Class Action Alert for C3.ai, Inc. Investors - Join Now!

Updated Category News Views 123

Opportunity for C3.ai, Inc. Shareholders to Join Class Action Attention, shareholders of C3.ai, Inc. (NYSE: AI). A significant class action suit is currently underway, and your involvement could be crucial. If you purchased shares during the class period, there may be an opportunity for you to participate in a recovery process without the requirement of being a lead...

Continue Reading
EyePoint Pharmaceuticals: Innovations and Financial Insights

Updated Category News Views 224

EyePoint Pharmaceuticals Set to Showcase Q2 Financials EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pioneering company dedicated to developing advanced therapeutics for serious retinal diseases, plans to share its second quarter 2025 financial results. This announcement will be accompanied by a live conference call and webcast on a scheduled day, promising to provide...

Continue Reading